New Jersey Harm Reduction Coalition (NJHRC) announced today that the organization is expanding its mail-based naloxone and harm reduction program. To manage the expansion, NJHRC is pleased to announce the hire of Sheilah Powell (she/her) as Manager of Mail-Based Services and Community Distribution.
Written Testimony to the New Jersey Opioid Settlement Advisory Council Dear Members of the New Jersey Opioid Settlement Advisory Council, It’s widely recognized that we won’t be able to arrest our way out of the overdose crisis and that drug use is a public health issue, not a criminal one. With opioid settlement funds, New … Read more
This checklist is a guide of elements to consider when reviewing the application for authorization and designing your syringe access program.
Earlier today, the New Jersey State Senate approved a bill upgrading fentanyl penalties (S-3325) by a vote of 32-0. This week, the Star-Ledger editorial board also opposed the bill, calling it “a return to the failed drug war.” Lawmakers previously received an open letter from 40+ public health, harm reduction, civil rights organizations warning that … Read more
On Wednesday, public health, recovery, and racial justice organizations sent a letter to the Senate Budget Committee, along with legislative leadership and Governor Murphy, urging them to oppose Senate Bill 3325, which proposes harsh new penalties for fentanyl. The bill will be heard by the Senate Budget Committee at its hearing today at 1pm. “The … Read more
On Thursday, April 27, the U.S. Attorney’s Office District of New Jersey shut down a pain treatment practice in Cherry Hill that was serving 300-400 patients across Camden, Burlington, Ocean, Cape May, & Gloucester Counties.For anyone who uses secondhand prescription medicines in these counties (i.e., not directly from the pharmacy or a script in your … Read more